1. Home
  2. PGEN vs NHI Comparison

PGEN vs NHI Comparison

Compare PGEN & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$7.02

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo National Health Investors Inc.

NHI

National Health Investors Inc.

N/A

Current Price

$66.99

Market Cap

3.2B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
NHI
Founded
1998
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
PGEN
NHI
Price
$7.02
$66.99
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$13.65
★ $78.50
AVG Volume (30 Days)
★ 4.5M
267.0K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
★ 5.62%
EPS Growth
N/A
★ N/A
EPS
0.03
★ 1.97
Revenue
$230,981,000.00
★ $375,628,000.00
Revenue This Year
$2,335.22
$20.56
Revenue Next Year
$85.34
$6.66
P/E Ratio
$223.17
★ $33.97
Revenue Growth
N/A
★ 12.07
52 Week Low
$3.04
$63.51
52 Week High
$8.98
$91.38

Technical Indicators

Market Signals
Indicator
PGEN
NHI
Relative Strength Index (RSI) 50.05 52.38
Support Level $6.57 $63.51
Resistance Level $7.44 $74.17
Average True Range (ATR) 0.42 1.37
MACD -0.03 0.35
Stochastic Oscillator 55.14 73.68

Price Performance

Historical Comparison
PGEN
NHI

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About NHI National Health Investors Inc.

National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.

Share on Social Networks: